Stocklytics Platform
Asset logo for symbol MRNA
Moderna
MRNA57
$32.99arrow_drop_up3.35%$1.07
S&P500
Asset logo for symbol MRNA
MRNA57

$32.99

arrow_drop_up3.35%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Moderna (MRNA) Stocklytics Forecast

Moderna Inc, MRNA is a biotechnology company that focuses on developing innovative mRNA-based therapeutics and vaccines. The company has gained significant attention in recent years, especially with the development of its COVID-19 vaccine. Investors are keen to know about the future prospects of Moderna and its stock price prediction. While it is important to note that stock price predictions are subject to market volatility and various external factors, there are several indicators that can be considered.
Analysts have been closely monitoring Moderna Inc, MRNA and providing their price targets for the stock. The average price target for MRNA is $250, indicating a potential upside. It is worth noting that these price targets are forecasts and can change over time as new information becomes available. Furthermore, it is crucial to consider multiple analysts' price targets to get a comprehensive view of the stock's potential. The 2023 price target for Moderna Inc, MRNA is expected to be in the range of $220 to $280, according to analysts.
add Moderna  to watchlist

Keep an eye on Moderna

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Moderna (MRNA) stock?

Analysts have set a target price of $128.5 for Moderna (MRNA), based on forecasts from 20 analysts. The predicted price range extends from a high of $231 to a low of $69. This represents a potential increase of up to 600.21% and a decrease of 109.15% from the current price of $32.99. These forecasts are as of 2023 Aug 03.
help

What are the analyst ratings for Moderna (MRNA) stock?

Currently, there are no analyst ratings available for Moderna (MRNA), possibly due to insufficient coverage or recent updates.
help

What is the AI price prediction for Moderna (MRNA) stock?

At present, there is no AI or machine-learning-based price prediction available for Moderna (MRNA) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level